ArticleJournal of experimental & clinical cancer research : CR2025

An immunometabolic prodrug strategy overcomes DHODH inhibitor resistance in refractory melanoma.

Yongrui Hai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.